MicroRNA-33 in atherosclerosis etiology and pathophysiology

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 201-208

  Chen, Wu Jun ^a   Zhang, Min ^a   Zhao, Guo Jun ^a   Fu, Yuchang ^b   Zhang, Da Wei ^c   Zhu, Hai Bo ^d   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Atherosclerosis; Etiology; MicroRNA 33; Pathophysiology

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ADENOSINE TRIPHOSPHATASE; BILE ACID; CHOLESTEROL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIN D1; CYCLIN DEPENDENT KINASE 6; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; GLYCINE AMIDINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 10; MICRORNA; MICRORNA 33; MYC PROTEIN; PHOSPHOLIPID; PROTEIN KINASE PIM 1; PROTEIN P53; RECEPTOR INTERACTING PROTEIN 140; SIRTUIN 6; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ATHEROSCLEROSIS; BILE ACID METABOLISM; BIOGENESIS; BONE MARROW CELL; CARDIOMETABOLIC RISK; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; ENERGY METABOLISM; FATTY ACID METABOLISM; GENE EXPRESSION; GENE TARGETING; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; INTRON; LIPID METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; CARDIOVASCULAR SYSTEM; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FATTY ACIDS; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN; LIPIDS; MICRORNAS; RISK FACTORS;

EID: 84875056553     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.11.025     Document Type: Review

References (67)

1. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
2. Murphy A.J., Westerterp M., Yvan-Charvet L., et al. Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells. Biochim Biophys Acta 1821, 2012:513-521.
3. Chen W.J., Yin K., Zhao G.J., et al. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis 2012, 222:314-323.
4. Sacco J., Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol 2012, 23:220-225.
5. Bommer G.T., MacDougald O.A. Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. Cell Metab 2011, 13:241-247.
6. Rayner K.J., Sheedy F.J., Esau C.C., et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest 2011, 121:2921-2931.
7. Rayner K.J., Esau C.C., Hussain F.N., et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011, 478:404-407.
8. Gao W., He H.W., Wang Z.M., et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 2012, 11:55.
9. Raitoharju E., Lyytikainen L.P., Levula M., et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219:211-217.
10. Fan Y.M., Karhunen P.J., Levula M., et al. Expression of sterol regulatory element-binding transcription factor (SREBF) 2 and SREBF cleavage-activating protein (SCAP) in human atheroma and the association of their allelic variants with sudden cardiac death. Thromb J 2008, 6:17.
11. Iwakiri Y. A role of miR-33 for cell cycle progression and cell proliferation. Cell Cycle 2012, 11:1057-1058.
12. Rayner K.J., Suarez Y., Davalos A., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
13. Najafi-Shoushtari S.H., Kristo F., Li Y., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
14. Marquart T.J., Allen R.M., Ory D.S., et al. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 2010, 107:12228-12232.
15. Horie T., Ono K., Horiguchi M., et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A 2010, 107:17321-17326.
16. Gerin I., Clerbaux L.A., Haumont O., et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 2010, 285:33652-33661.
17. de Beer M.C., Ji A., Jahangiri A., et al. ATP binding cassette G1-dependent cholesterol efflux during inflammation. J Lipid Res 2011, 52:345-353.
18. Tang S.L., Chen W.J., Yin K., et al. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRalpha through the IGF-I-mediated signaling pathway. Atherosclerosis 2012, 222:344-354.
19. Hao X.R., Cao D.L., Hu Y.W., et al. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 2009, 203:417-428.
20. Hu Y.W., Ma X., Li X.X., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-e43.
21. Singaraja R.R., Stahmer B., Brundert M., et al. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice. Arterioscler Thromb Vasc Biol 2006, 26:1821-1827.
22. Vaisman B.L., Lambert G., Amar M., et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001, 108:303-309.
23. Joyce C.W., Wagner E.M., Basso F., et al. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 2006, 281:33053-33065.
24. Aiello R.J., Brees D., Bourassa P.A., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002, 22:630-637.
25. Yu X., Li X., Zhao G., et al. OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARalpha-signaling pathway in macrophages. Acta Biochim Biophys Sin (Shanghai) 2012, 44:119-128.
26. Ozsait B., Komurcu-Bayrak E., Levula M., et al. Niemann-Pick type C fibroblasts have a distinct microRNA profile related to lipid metabolism and certain cellular components. Biochem Biophys Res Commun 2010, 403:316-321.
27. Wang D., Xia M., Ya X., et al. Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Cir Res 2012, 111:967-981.
28. Ramirez C.M., Davalos A., Goedeke L., et al. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 2011, 31:2707-2714.
29. Kim J., Yoon H., Ramirez C.M., et al. miR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 2012, 235:476-483.
30. Sun D., Zhang J., Xie J., et al. MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7. FEBS Lett 2012, 586:1472-1479.
31. Borel F., Han R., Visser A., et al. Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 2012, 55:821-832.
32. Hoekstra M., van der Sluis R.J., Kuiper J., et al. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J Nut Biochem 2012, 23:622-628.
33. Davalos A., Goedeke L., Smibert P., et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 2011, 108:9232-9237.
34. Allen R.M., Marquart T.J., Albert C.J., et al. miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med 2012, 4:882-895.
35. Chen W.J., Yin K., Zhao G.J., et al. microRNAs: a new mechanisms for regulation of lipid metabolism. Prog Biochem Biophys 2010, 38:781-790.
36. Hicks J.A., Trakooljul N., Liu H.C. Discovery of chicken microRNAs associated with lipogenesis and cell proliferation. Physiol Genomics 2010, 14:185-193.
37. Shah S., Sanford U.R., Vargas J.C., et al. Strain background modifies phenotypes in the ATP8B1-deficient mouse. PloS One 2010, 5:e8984.
38. Kim H.S., Xiao C., Wang R.H., et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab 2010, 12:224-236.
39. Ho P.C., Chang K.C., Chuang Y.S., et al. Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J 2011, 25:1758-1766.
40. Trauner M., Claudel T., Fickert P., et al. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 2010, 28:220-224.
41. Chan J., Vandeberg J.L. Hepatobiliary transport in health and disease. Clin Lipidol 2012, 7:189-202.
42. Morotti R.A., Suchy F.J., Magid M.S. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Semin Liver Dis 2011, 31:3-10.
43. Abumrad N.A., Davidson N.O. Role of the gut in lipid homeostasis. Physiol Rev 2012, 92:1061-1085.
44. Iliopoulos D., Drosatos K., Hiyama Y., et al. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 2010, 51:1513-1523.
45. Vickers K.C., Remaley A.T. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012, 23:91-97.
46. Vickers K.C., Palmisano B.T., Shoucri B.M., et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
47. Tsai N.P., Lin Y.L., Wei L.N. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 2009, 424:411-418.
48. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
49. Kawahara T.L., Rapicavoli N.A., Wu A.R., et al. Dynamic chromatin localization of Sirt6 shapes stress- and aging-related transcriptional networks. PLoS Genet 2011, 7:e1002153.
50. Yin K., Deng X., Mo Z.C., et al. Tristetraprolin-dependent post-transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. J Biol Chem 2011, 286:13834-13845.
51. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
52. Kruit J.K., Wijesekara N., Westwell-Roper C., et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired beta-cell function. Diabetes 2012, 61:659-664.
53. Jelinek D., Millward V., Birdi A., et al. Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet 2011, 20:312-321.
54. Wijesekara N., Zhang L.H., Kang M.H., et al. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes 2012, 61:653-658.
55. Anunciado-Koza R.P., Zhang J., Ukropec J., et al. Inactivation of the mitochondrial carrier SLC25A25 (ATP-Mg2+/Pi transporter) reduces physical endurance and metabolic efficiency in mice. J Biol Chem 2011, 286:11659-11671.
56. Rottiers V., Najafi-Shoushtari S.H., Kristo F., et al. MicroRNAs in metabolism and metabolic diseases. Spring Harb Symp Quant Biol 2011, 76:225-233.
57. Sriram V., Patterson C. Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery. Circulation 2001, 103:2414-2419.
58. Mercer J., Bennett M. The role of p53 in atherosclerosis. Cell Cycle 2006, 5:1907-1909.
59. Cirera-Salinas D., Pauta M., Allen R.M., et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012, 11:922-933.
60. Herrera-Merchan A., Cerrato C., Luengo G., et al. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 2010, 9:3277-3285.
61. Thomas M., Lange-Grunweller K., Weirauch U., et al. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2012, 31:918-928.
62. Katakami N., Kaneto H., Hao H., et al. Role of pim-1 in smooth muscle cell proliferation. J Biol Chem 2004, 279:54742-54749.
63. Takwi A.A., Li Y., Becker Buscaglia L.E., Zhang J., et al. A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med 2012, 4:896-909.
64. Blandino G., Valerio M., Cioce M., et al. Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC. Nat Commun 2012, 3:865.
65. Napoli C., Lerman L.O., de Nigris F., et al. c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?. Neoplasia 2002, 4:185-190.
66. Yvan-Charvet L., Pagler T., Gautier E.L., et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010, 328:1689-1693.
67. Reboul E., Borel P. Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog Lipid Res 2011, 50:388-402.